Account
GenY Medium wins digital mandate for Digi-Prex
MUMBAI: GenY Medium (GenY) is now the digital partner for Digi-Prex, the Indian health-tech start-up which delivers prescription medicines at consumer’s doorstep.
Digi-Prex provides patients with one-stop online ordering using WhatsApp and also a reminder system for their monthly supply of medication. The ten-month-old start-up currently has its presence in Hyderabad having a customer base of more than ten thousand customers.
GenY Medium is a full-service digital agency that enhances the digital presence of leading businesses by combining the art of marketing with the science of digital.
In accordance with the requisites of the mandate, GenY will be focusing on hyper-personalised performance marketing which would help with Digi-Prex’s brand growth. In addition to that, GenY will also leverage digital campaigns in vernacular languages to create large scale awareness about their platform. Digi-Prex has given GenY a full-service mandate which includes digital brand building and performance marketing.
Speaking about the win, GenY Medium co-founder & CEO Yashwant Kumar said, “We are excited to partner with Digi-Prex. We are very confident that by leveraging our expertise and experience in performance marketing we will significantly increase the brand reach as well as customer acquisition.”
Digi-Prex CEO Samarth Sindhi added, “We are looking forward to work with the team GenY. We are hopeful that with their specialization in performance marketing and also domain expertise in healthcare, they will help us grow our customer acquisition and retention efforts exponentially.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
